KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short-Term Debt issuances (2020 - 2025)

Idexx Laboratories has reported Short-Term Debt issuances over the past 4 years, most recently at -$57.0 million for Q4 2025.

  • Quarterly results put Short-Term Debt issuances at -$57.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $148.0 million (changed N/A YoY), and the annual figure for FY2025 was $148.0 million, changed.
  • Short-Term Debt issuances for Q4 2025 was -$57.0 million at Idexx Laboratories, up from -$124.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for IDXX hit a ceiling of $326.5 million in Q1 2022 and a floor of -$167.5 million in Q2 2023.
  • Median Short-Term Debt issuances over the past 3 years was -$14.0 million (2023), compared with a mean of $29.5 million.
  • Peak annual rise in Short-Term Debt issuances hit 145.18% in 2023, while the deepest fall reached 179.38% in 2023.
  • Idexx Laboratories' Short-Term Debt issuances stood at -$54.0 million in 2022, then surged by 74.07% to -$14.0 million in 2023, then crashed by 307.14% to -$57.0 million in 2025.
  • The last three reported values for Short-Term Debt issuances were -$57.0 million (Q4 2025), -$124.0 million (Q3 2025), and $259.5 million (Q2 2025) per Business Quant data.